Status:
RECRUITING
The Association Between Glycemic Metrics and Cardiovascular Markers in Patients With Type 1 Diabetes.
Lead Sponsor:
Attikon Hospital
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
12-80 years
Brief Summary
In this cross-sectioanl study, 90 patients aged \>12 years old with T1DM who are on MiniMed 780G system will be included.The investigators aim to assesse the association of patients' adherence to Medi...
Detailed Description
This cross-sectional study will include 90 participants, children adolescents and young adults (12\> years old) with T1D that are on MiniMed 780G system. Participants will be evaluated for adherence t...
Eligibility Criteria
Inclusion
- Clinical diagnosis of type 1 diabetes \>1 year prior to consent date. Diagnosis of type 1 diabetes is based on the investigator's judgment; C peptide level and antibody determinations are not required.
- HbA1c \< 12.5%
- Age \>7years at the initiation of the system
- Patients with Minimed 780G
- History of 3 clinic visits in the last year
Exclusion
- Diabetic Ketoacidosis in the 6 months prior to screening visits
Key Trial Info
Start Date :
January 15 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06978387
Start Date
January 15 2025
End Date
September 1 2025
Last Update
May 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Attikon University General Hospital
Chaïdári, Greece, 124 62